New intracoronary stent designs: Form follows function versus function follows form

Current Opinion in Cardiology

Volumn 13, Issue 4, 1998, Pages 232-239

  Fry, Edward T A ^a   Hermiller, James B ^a   Pinkerton, Cass A ^a  

^a Indiana Heart Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; HUMAN; PRIORITY JOURNAL; REGISTER; RESTENOSIS; REVIEW; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0031827652     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199807000-00003     Document Type: Review

References (46)

1. Waller BF: "Crackers, breakers, stretchers, drillers, scrapers, shavers, burners, welders, and melters": the future treatment of atherosclerotic coronary artery disease? A clinical morphologic assessment J Am Coll Cardiol 1989, 13:969-987.
2. Popma JJ, Lansky AJ, Ito S, Mintz GS, Leon MB: Contemporary stent designs. Technical considerations, complications, role of intravascular ultrasound, and anticoagulation therapy. Prog Cardiovasc Dis 1996, 39:111-128. Excellent review of new stent designs, optimal stent deployment strategies, adjunctive pharmacology, and stent-related clinical traits.
3. Belli G, Ellis SG, Topol EJ: Stenting for ischemic heart disease. Prog Cardiovasc Dis 1997, 40:159-182.
4. King SB, Yeh W, Holubkov R, et al.: Balloon angioplasty versus new device intervention: clinical outcomes. A comparison of the NHLBI PTCA and NACI registries. J Am Coll Cardiol 1998, 31:558-566. Retrospective comparison of procedural databases from the "balloon era" and "new device era," providing insight into how far the field of interventional cardiology has evolved.
5. Colombo A, Hall P, Nakamura S, et al.: Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995, 91:1676-1688.
6. Hall P, Nakamura S, Maiello L, et al.: A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 1996, 93:215-222.
7. Schuhlen H, Hadamitzky M, Walter H, Ulm K, Schomig A: Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the intracoronary stenting and antithrombotic regimen (ISAR) trial. Circulation 1997, 95:2015-2021.
8. Fry ET, Hermiller JB, Peters TF, et al.: Indications for and applications of the Gianturco-Roubin coronary stent. Cardiol Clin 1994, 12:631-649.
9. Schatz RA, Baim DS, Leon MB, et al.: Clinical experience with the Palmaz-Schatz coronary stent: initial results of a multicenter study. Circulation 1991, 83:148-161.
10. Gregoire J, Smith DG, Ragheb A, Sangiorgi G, Hodge DO, Schwartz RS, Holmes DR, Garrat KN: Stent collapse resistance to external pressure: comparison between coil and slotted tube stent designs. J Am Coll Cardiol 1998, 31:414A.
11. Serruys PW, de Jaegere P, Kiemeneij F, et al.: A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease: Benestent study group. N Engl J Med 1994, 331:489-495. Landmark European multicenter study demonstrating reduced angiographic restenosis and need for repeat revascularization with elective stenting using the Palmaz-Schatz stent in de novo lesions as compared to balloon angioplasty alone.
12. Fischman DL, Leon MB, Baim DS, et al.: A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease: stent restenosis study investigators. N Engl J Med 1994, 331:496-501. Companion landmark article paralleling findings in BENESTENT, confirming the benefits of elective stenting.
13. George BS, Voorhees WD, Roubin GS, et al.: Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes. J Am Coll Cardiol 1993, 22:135-143. Initial report of the benefits of coronary stenting in the management of acute and threatened closure during coronary intervention. This trial served as the basis for approval of the first stent in the United States.
14. Leon MB, Fry ET, O'Shaughnessy CD, Yakubov SJ, Carroza JP, Kereiakes KJ, Popma JJ, Warth DC, Thompson MA, Rogers EW, Dean LS, Pinkerton CA: Preliminary multicenter experiences with the new GRII stent for abrupt and threatened closure syndrome [abstract]. Circulation 1996, 94:1-207.
15. Fry ETA, Hermiller JB, Pinkerton CA, George BS, Yakubov SJ, O'Shaughnessy CD, Kereiakes DJ, Dean LS, Roubin GS, Voorhees WD, Leon MB for the GRII Clinical Investigators: Effect of lesion characteristics and number of stents on 6 month outcome following treatment of acute or threatened closure with the GRII coronary stent [abstract]. Am J Cardiol 1997, 80:7A.
16. Ozaki Y, Keane D, Ruykrok P, et al.: Acute clinical and angiographic results with the new AVE micro coronary stent in bailout management. Am J Cardiol 1995, 76:112-116.
17. Garret KN, Buchbinder M, Heuser RR, Whitlow P, White CJ: Late clinical outcome after Medtronic Wiktor coronary stent placement: American investigators registry report [abstract]. Circulation 1996, 94:1-206.
18. Zidar JP, O'Shaughnessy CD, Dean LS, Holmes DR, Moore PB, Rogers EW, Fry ET, Raizner AE, Voorhees WD, Leon MB: Elective GRII stenting in small vessels: multicenter results [abstract]. J Am Coll Cardiol 1998, 31:274A.
19. Leon MB, Popma JJ, O'Shaughnessy C, Dean LS, Lansky AJ, Fry ET. Curran MJ: Quantitative angiographic outcomes after Gianturco-Roubin II stent implantation in complex lesion subsets [abstract]. Circulation 1997, 96:1-653.
20. Multicenter GRII Investigator Group, Leon M: A multicenter randomized trial comparing the second generation Gianturco-Roubin (GRII) and the Palmaz-Schatz coronary stents [abstract]. J Am Coll Cardiol 1997, 29:170A.
21. Anzuini A, Rosanio S, LeGrand V, et al.: Wiktor stent for treatment of chronic total coronary artery occlusions: short-and long-term clinical and angiographic results from a large multicenter experience. J Am Coll Cardiol 1998, 31:283-288.
22. Sirnes PA, Golf S, Myreng Y, et al.: Stenting in chronic coronary occlusion (SICCO): a randomized controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol 1996, 28:1444-1451.
23. Rogers C, Edelman ER: Endovascular stent design dictates experimental restenosis and thrombosis. Circulation 1995, 91:2995-3001. Histologic study of vessel injury response, monocyte adhesion, and neointimal proliferation in animal models, comparing two stent designs. Authors speculate on clinical implications.
24. Carrozza JP, Hermiller JB, Linnemeier TJ, Popma JJ, Yock PG, Roubin GS, Dean LS, Kuntz RE, Robertson L, Ho KK, Cutlip DE, Baim DS: Quantitative coronary angiographic and intravascular ultrasound assessment of a new nonarticulated stent: report from the advanced cardiovascular systems MultiLink stent pilot study. J Am Coll Cardiol 1998, 31:50-56. Analysis of stent deployment and expansion mechanics using quantitative coronary angiography and intravascular ultrasound. Similar methods of analysis with other stent designs will help define optimal deployment strategy for each.
25. Baim D, Cutlip DE, Midei M, et al.: Acute 30 day and late clinical events in the randomized parallel group comparison of the ACS Multi-Link coronary stent system and the Palmaz-Schatz stent [abstract]. Circulation 1997, 96:1-593.
26. Heuser RR, Kuntz RE, Lansky JA, et al.: The SMART Trial: acute outcome indicates superior efficacy with the AVE stent [abstract]. Circulation 1997, 96:1-593.
27. Heuser R, Kuntz R, Lansky A, Ho KK, Pino Mauch B, Reduto L, Badger R, Coleman P, Whitlow P: Six month clinical and angiographic results of the SMART trial [abstract]. J Am Coll Cardiol 1998, 31:64A.
28. Almagor Y, Feld S, Kiemeneij F, Serruys PW, Morice MC, Colombo A, Macaya C, Guermonprez JL, Marco J, Erbel R, Penn IM, Bonan R, Leon MB: First International New Intravascular Rigid-Flex Endovascular Stent Study (FINESS): clinical and angiographic results after elective and urgent stent implantation. J Am Coll Cardiol 1997, 30:847-854.
29. Baim D: Acute and 30 day clinical trial results of the NIRVANA trial [abstract]. Circulation 1997, 96:1-594.
30. Kobayashi Y, De Gregorio J, Reimers B, Di Mario C, Finci L, Colombo A: Immediate and follow-up results following the implantation of the long and short NIR stent: comparison with the Palmaz-Schatz stent [abstract]. J Am Coll Cardiol 1998, 31:312A.
31. Han RO, Schwartz RS, Mann JT, Sketch MH, Feldman RL, Midei MG, Safian RD, Brown CL, Rogers EW, Savage MP, Murphy BE, Werner W, Palacios IF, Goldberg S: Comparative efficacy of self expanding and balloon expandable stents for the reduction of restenosis. J Am Coll Cardiol 1998, 31:314A.
32. Isshiki T, Eto K, Ochiai M, Mitani H, Kondo K, Takeshita S, Sato T: Nitinol RADIUS stent induces less platelet aggregation than stainless steel Palmaz-Schatz/Gianturco-Roubin II stents [abstract]. J Am Coll Cardiol 1998, 31:312A.
33. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L: Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987, 316:701-706 First report of coronary stenting. Initial experiences were exciting and encouraging, but enthusiasm was soon muted by high rates of stent thrombosis with associated mortality and morbidity.
34. Strauss BH, Serruys PW, Bertrand ME, et al.: Quantitative angiographic follow-up of the coronary Wallstent in native vessels and bypass grafts (European experience-March 1986 to March 1990). Am J Cardiol 1992, 69:475-481.
35. Ozaki Y, Keane D, Ruygrok P, et al.: Six month clinical and angiographic outcome of the new less shortening Wallstent in native coronary arteries. Circulation 1996, 93:2114-2120.
36. Bilodeau L, Schreiber T, Hilton JD, et al.: The Wallstent in native coronary arteries (WIN) multicenter trial: acute results and 6 months follow-up of the feasibility cohort [abstract]. J Am Coll Cardiol 1998, 31:313A.
37. Schomig A, Neumann FJ, Kastrati A, et al.: A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary stents. N Engl J Med 1996, 334:1084-1089. Important randomized trial comparing poststent antithrombotic therapy with asprin and ticlopidine versus aspirin, warfarin, and heparin. Results demonstrated marked superiority of antiplatelet therapy alone in improving acute and late outcomes and decreasing complications.
38. The EPIC Investigators: Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty. N Engl J Med 1994, 330:956-961.
39. Kereiakes DJ, Lincoff AM, Simoons ML. et al.: Complimentary of stenting and abciximab for percutaneous coronary intervention [abstract]. J Am Coll Cardiol 1998, 31:54A.
40. Aggarwal RK, Ireland DC, Azrin MA, et al.: Anti-thrombotic properties of stents eluting platelet glycoprotein IIb/IIIa antibody [abstract]. Circulation 1995, 92:1-488.
41. Serruys PW, Emanuelsson H, van der dessen W, et al.: Heparin coated Palmaz-Schatz stents in human coronary arteries: early outcome of the Benestent-II Pilot Study. Circulation 1996, 93:412-422.
42. Kornowshi R, Hong MK, Ragheb AO, Bramwell O, Leon MB: Slow release taxol coated GRII stents reduce neointima formation in a porcine coronary in-stent restenosis model [abstract]. Circulation 1997, 96:IAU: 1 meant?-341.
43. Hong MK, Mintz GS, Popma JJ, Kent KM, Pichard AD, Satler LF, Wong SC, Bucher T, Leon MB: Angiographic results and late clinical outcomes utilizing a stent synergy (pre-stent atheroablation) approach in complex lesion subsets. J Invasive Cardiol 1996, 8:15-22.
44. Tierstein PS, Massullo V, Jani S, et al.: Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997, 336:1697-1703. First randomized controlled study demonstrating the efficacy of intracoronary gamma irradiation in preventing recurrent in-stent restenosis. These provocative findings have helped launch an entire new area in coronary intervention.
45. Hermiller JB, Fry ET, Peters TF, et al.: Late coronary artery stenosis regression within the Gianturco-Roubin intracoronary stent. Am J Cardiol 1996, 77:247-251. Quantitative coronary angiography analysis of serial angiograms following intra-coronary stenting demonstrating long-term improvement in minimum lumen diameter and decreased percent stenosis.
46. Ruygrok PN, Serruys PW: Intracoronary stenting from concept to custom. Circulation 1996, 94:882-890. Concise, complete historical perspective of intracoronary stenting with speculation concerning future directions.